Rodríguez-Portales J A, Fardella C
Department of Endocrinology, Metabolism and Nutrition School of Medicine, Pontificia Universidad Católica de Chile, Santiago.
J Endocrinol Invest. 1994 May;17(5):307-11. doi: 10.1007/BF03348986.
To examine the effects of primary hyperparathyroidism separately from those of hypertension per se on blood pressure regulation in patients with primary hyperparathyroidism, we studied the pressor response to infused angiotensin II (AII) and to norepinephrine (NE) in 7 normotensive patients with primary hyperparathyroidism before and after surgical cure, and compared it to that observed in 10 subjects with idiopathic hypertension and 10 normal controls. While the subjects were on an ad libitum diet, we measured urinary and plasma electrolytes, creatinine, and plasma renin activity. Except for calcium, these values were not significantly different among the three groups. The blood pressure was measured basally and in response to graded doses of AII or of NE until a 20-mmHg increase in the diastolic blood pressure was reached ("pressor dose"). The pressor doses of AII and of NE were lower in the normotensive patients with primary hyperparathyroidism than in normal controls [4.6 +/- 2.0 vs. 7.3 +/- 3.5 ng/kg/min (p < 0.05) and 164 +/- 114 vs. 302 +/- 176 ng/kg/min (p < 0.05) respectively] and not significantly different from those found in idiopathic hypertension (3.1 +/- 1.2 and 137 +/- 95 ng/kg/min). When the patients with primary hyperparathyroidism were studied again between 2-6 months after surgical cure, their pressor doses of AII and of NE remained unchanged from their preoperative values (5.4 +/- 2.9 and 137 +/- 80 mg/kg/min). We conclude that the hyperparathyroid condition can disrupt the normal responsiveness to pressor agents even if the blood pressure remains within normal limits, and that this abnormality may persist after surgical cure.
为了在原发性甲状旁腺功能亢进症患者中,将原发性甲状旁腺功能亢进症的影响与高血压本身对血压调节的影响区分开来进行研究,我们对7例血压正常的原发性甲状旁腺功能亢进症患者在手术治愈前后对输注血管紧张素II(AII)和去甲肾上腺素(NE)的升压反应进行了研究,并将其与10例特发性高血压患者和10例正常对照者的反应进行了比较。在受试者自由饮食期间,我们测量了尿和血浆电解质、肌酐以及血浆肾素活性。除钙外这,些值在三组之间无显著差异。基础状态下测量血压,并测量对不同剂量AII或NE的反应,直至舒张压升高20 mmHg(“升压剂量”)。原发性甲状旁腺功能亢进症的血压正常患者对AII和NE的升压剂量低于正常对照者[分别为4.6±2.0 vs. 7.3±3.5 ng/kg/min(p<0.05)和164±114 vs. 302±176 ng/kg/min(p<0.05)],与特发性高血压患者的升压剂量无显著差异(3.1±1.2和137±95 ng/kg/min)。当原发性甲状旁腺功能亢进症患者在手术治愈后2至6个月再次接受研究时,他们对AII和NE的升压剂量与术前值相比没有变化(5.4±2.9和137±80 mg/kg/min)。我们得出结论,甲状旁腺功能亢进状态即使血压仍在正常范围内,也会破坏对升压剂的正常反应性,并且这种异常在手术治愈后可能持续存在。